19
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T4044 | DprE1-IN-2 | Antibacterial , DprE1 | |
DprE1-IN-2 is an effective DprE1 inhibitor. | |||
T3224 | TBA-7371 | AZ 7371,DprE1-IN-1 | Antibacterial , PDE , DprE1 |
TBA-7371 (DprE1-IN-1) is a potent inhibitor of DprE1 and PDE6. | |||
T27206 | DprE1-IN-377790 | ||
DprE1-IN-377790 is a novel DprE1 inhibitor, killing M. tuberculosis. | |||
T79440 | DprE1-IN-5 | ||
DprE1-IN-5 (Compound 10), a potent DprE1 inhibitor, exhibits anti-TB activity with an MIC of 4 μM against the Mtb H37Rv strain and demonstrates antimycobacterial efficacy against drug-resistant strains. Additionally, it ... | |||
T62741 | DprE1-IN-1 | ||
DprE1-IN-1 is a potent, orally active DprE1 inhibitor that exhibits good hepatocyte stability, low cytotoxicity and low hERG channel inhibition. DprE1-IN-1 has good anti-branched bacilli activity in macrophages, reducing... | |||
T62147 | DprE1-IN-4 | ||
DprE1-IN-4 is a potent, non-covalent inhibitor of DprE1 (IC50: 0.90 μg/mL). DprE1-IN-4 has acceptable pharmacokinetic properties and has a significant bactericidal effect in a mouse model of acute tuberculosis. | |||
T78883 | DprE1-IN-9 | ||
DprE1-IN-9 (compound B18) is an efficient reversible inhibitor of DprE1, interacting with the enzyme's receptor cavity. It exhibits potent antimycobacterial properties, demonstrating activity against both non-pathogenic ... | |||
T79442 | DprE1-IN-7 | ||
DprE1-IN-7 (Compound 64) is a DprE1 inhibitor with potent anti-tuberculosis (TB) activity, demonstrating a minimum inhibitory concentration (MIC) of 1 μM against the Mtb H37Rv strain. It exhibits antimycobacterial effect... | |||
T79628 | DprE1-IN-8 | Antibiotic | |
DprE1-IN-8 is a potent inhibitor of DprE1, exhibiting an IC50 of less than 0.75 μM. It has demonstrated significant activity against Mtb H37Rv, with an IC50 value of 6 nM, making it applicable in tuberculosis research [1... | |||
T79441 | DprE1-IN-6 | ||
DprE1-IN-6 (Compound 56) is a DprE1 inhibitor with demonstrated anti-TB activity, exhibiting a minimum inhibitory concentration (MIC) of 1 μM against the Mtb H37Rv strain, along with efficacy against drug-resistant mycob... | |||
T3583 | Macozinone | PBTZ169 | Antibacterial , DprE1 |
Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043. | |||
T5315 | TCA1 | TCA-1,TCA 1 | Antibacterial , Antibiotic |
TCA1 (TCA 1) is a small molecule with activity against drug-resistant and persistent tuberculosis. | |||
T3582 | BTZ043 | Antibacterial , Antibiotic , DprE1 | |
BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro. | |||
T6425 | BTZ043 Racemate | BTZ044,BTZ10526038,Benzothiazinone 10526038 | Antibacterial , DprE1 |
BTZ043 Racemate (Benzothiazinone 10526038) is a decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1) inhibitor, used as a new antimycobacterial agent. | |||
T25267 | Cmpd 339509 | Cmpd339509,Cmpd-339509 | |
Cmpd 339509 is a DprE1 inhibitor. DprE1 is an epimerase required for cell wall biosynthesis. | |||
T79281 | Antimycobacterial agent-6 | ||
Antimycobacterial agent-6 (compound 25) effectively inhibits Mycobacterium tuberculosis, including wild-type and fluoroquinolone-resistant strains, by targeting the Mtb DprE1-C387S mutant. It displays minimal inhibitory ... | |||
T63414 | Antitubercular agent-31 | ||
Antitubercular agent-31 is an antitubercular agent that inhibits M. tuberculosisH37Rv (MIC: 0.03 μM) and also inhibits DprE1 (IC50: 1.1 μM). | |||
T63319 | Antitubercular agent-32 | ||
Antitubercular agent-32 is a Benzothiazinone derivative that inhibits Mycobacterium tuberculosis and exhibits good metabolic stability and water solubility. Antitubercular agent-32 can act on decaprenylphosphoryl-β-D-rib... | |||
T37880 | OPC-167832 | ||
OPC-167832 is a potent and orally active dprE1 Inhibitor with an IC50 of 0.258 μM. OPC-167832 has antituberculosis activity and can be used for the research of tuberculosis caused by Mycobacterium tuberculosis[1]. OPC-16... |